Danny is a European Registered Toxicologist and has 20 years of experience in oncology drug development, which includes research positions at the Netherlands Cancer Institute and Leiden University, and several positions within the pharmaceutical industry. In 2018 he co-founded D2Team, a consultancy company that provides non-clinical development services for the pharma/biotech industry. His experience covers bioanalysis, drug metabolism and biomarkers, and nonclinical toxicology support for small molecules and biologicals in all phases of drug development.